Wunmi Bakare

Wunmi is the co-founder of Sickle Cell Prodigy, a 501(c)(3) nonprofit redefining survivorship for individuals living with sickle cell disease who are exploring curative-intent therapies, including bone marrow transplant and gene-based therapy. A pioneering advocate in the rare disease community, she is recognized for advancing inclusion, challenging stigma, and elevating the patient voice. Diagnosed with the severe HbSS form of sickle cell disease in infancy, Wunmi underwent a successful allogeneic stem cell transplant in 2019 through a groundbreaking NIH clinical trial. 

At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.